GOING CONCERN AND MANAGEMENTS LIQUIDITY PLANS (Details Narrative) - USD ($) |
1 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Mar. 08, 2024 |
Apr. 24, 2024 |
Mar. 25, 2024 |
Jun. 30, 2024 |
Jun. 30, 2023 |
Dec. 31, 2023 |
|
| Working capital deficit | $ (7,142,958) | |||||
| Accrued interest | $ 57,412 | |||||
| Common stock price per share | $ 0.001 | $ 0.001 | ||||
| Cash | $ 8,365 | |||||
| Net cash used in operating activities | (491,541) | $ (968,898) | ||||
| Gross Proceeds | 235,396 | |||||
| Mr Lucido [Member] | ||||||
| Promissory note outstanding | $ 446,426 | |||||
| Professional fees | 90,000 | |||||
| Accrued interest | $ 7,858 | |||||
| Common stock shares issued | 460,477 | |||||
| Common stock price per share | $ 1.18 | |||||
| Lourdes Felix [Member] | ||||||
| Professional fees | $ 265,000 | |||||
| Common stock shares issued | 224,196 | |||||
| Common stock price per share | $ 1.18 | |||||
| Investors [Member] | ||||||
| Common stock shares issued | 15,000 | 15,000 | ||||
| Gross Proceeds | $ 15,000 | $ 13,350 | ||||
| Exercise price | $ 1.00 | $ 0.89 | ||||
| Unsecured Promissory Note Related Third Party [Member] | ||||||
| Issued Notes payable | $ 200,000 | |||||
| Notes payable interest rate | 8.00% | |||||
| February 22, 2024 [Member] | ||||||
| Description of funding | The grant provides for (i) $4,131,123 in funding during the first year, (ii) $3,638,268 during the second-year, and (iii) $3,260,586 during the third-year subject to the terms and conditions specified in the grant, including satisfactory progress of project and the availability of funds | |||||
| Awarded a grant | $ 11,029,977 | |||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Increase for accrued, but unpaid interest on the debt instrument for the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Including the current and noncurrent portions, carrying value as of the balance sheet date of all notes and loans payable (with maturities initially due after one year or beyond the operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The fair value of notes issued in noncash investing and financing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
- Definition Number of shares of stock issued attributable to transactions classified as other. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|